Cetero Research, the clinical research organization that fell under a U.S. Food and Drug Administration probe for allegedly falsifying clinical trial records, has reached a “final resolution” with regulators about which studies can stand and which ones must be redone.The FDA had raised questions about data from Cetero’s Houston bioanalytical laboratory over a five-year period [...]

Novel obesity treatment company EnteroMedics(NASDAQ:ETRM)that has survived a close brush with disaster recorded revenue for the first time since it was incorporated nearly eight years ago.On Tuesday, the company reported revenue of about $123,000 in the first quarter of the year that were garnered from the sale of its implantable neuromodulation system — Maestro RC [...]